164 related articles for article (PubMed ID: 7452464)
21. Characteristics of drug-phospholipid coprecipitates I: Physical properties and dissolution behavior of griseofulvin-dimyristoylphosphatidylcholine systems.
Venkataram S; Rogers JA
J Pharm Sci; 1984 Jun; 73(6):757-61. PubMed ID: 6737259
[TBL] [Abstract][Full Text] [Related]
22. Solid dispersions of itraconazole for inhalation with enhanced dissolution, solubility and dispersion properties.
Duret C; Wauthoz N; Sebti T; Vanderbist F; Amighi K
Int J Pharm; 2012 May; 428(1-2):103-13. PubMed ID: 22414388
[TBL] [Abstract][Full Text] [Related]
23. Gelucire 44/14 based immediate release formulations for poorly water-soluble drugs.
da Fonseca Antunes AB; De Geest BG; Vervaet C; Remon JP
Drug Dev Ind Pharm; 2013 May; 39(5):791-8. PubMed ID: 22871141
[TBL] [Abstract][Full Text] [Related]
24. Comparative dissolution studies for mefenamic acid-polyethylene glycol solid dispersion systems and tablets.
Owusu-Ababio G; Ebube NK; Reams R; Habib M
Pharm Dev Technol; 1998 Aug; 3(3):405-12. PubMed ID: 9742561
[TBL] [Abstract][Full Text] [Related]
25. Enhanced solubility of piperine using hydrophilic carrier-based potent solid dispersion systems.
Thenmozhi K; Yoo YJ
Drug Dev Ind Pharm; 2017 Sep; 43(9):1501-1509. PubMed ID: 28425323
[TBL] [Abstract][Full Text] [Related]
26. Influence of excipients on solubility and dissolution of pharmaceuticals.
Paus R; Prudic A; Ji Y
Int J Pharm; 2015 May; 485(1-2):277-87. PubMed ID: 25749073
[TBL] [Abstract][Full Text] [Related]
27. Preparation, characterization, and dissolution studies of ibuprofen solid dispersions using polyethylene glycol (PEG), talc, and PEG-talc as dispersion carriers.
Khan GM; Jiabi Z
Drug Dev Ind Pharm; 1998 May; 24(5):455-62. PubMed ID: 9876608
[TBL] [Abstract][Full Text] [Related]
28. Critical material attributes (CMAs) of strip films loaded with poorly water-soluble drug nanoparticles: I. Impact of plasticizer on film properties and dissolution.
Krull SM; Patel HV; Li M; Bilgili E; Davé RN
Eur J Pharm Sci; 2016 Sep; 92():146-55. PubMed ID: 27402100
[TBL] [Abstract][Full Text] [Related]
29. Development of prednisone:polyethylene glycol 6000 fast-release tablets from solid dispersions: solid-state characterization, dissolution behavior, and formulation parameters.
Leonardi D; Barrera MG; Lamas MC; Salomón CJ
AAPS PharmSciTech; 2007 Dec; 8(4):E108. PubMed ID: 18181529
[TBL] [Abstract][Full Text] [Related]
30. Anomalous properties of spray dried solid dispersions.
Al-Obaidi H; Brocchini S; Buckton G
J Pharm Sci; 2009 Dec; 98(12):4724-37. PubMed ID: 19455622
[TBL] [Abstract][Full Text] [Related]
31. Enhancement of the dissolution rate of a poorly water-soluble drug (tolbutamide) by a spray-drying solvent deposition method and disintegrants.
Takeuchi H; Handa T; Kawashima Y
J Pharm Pharmacol; 1987 Oct; 39(10):769-73. PubMed ID: 2891813
[TBL] [Abstract][Full Text] [Related]
32. Influence of spray drying and dispersing agent on surface and dissolution properties of griseofulvin micro and nanocrystals.
Shah DA; Patel M; Murdande SB; Dave RH
Drug Dev Ind Pharm; 2016 Nov; 42(11):1842-50. PubMed ID: 27080146
[TBL] [Abstract][Full Text] [Related]
33. To enhance dissolution rate of poorly water-soluble drugs: glucosamine hydrochloride as a potential carrier in solid dispersion formulations.
Al-Hamidi H; Edwards AA; Mohammad MA; Nokhodchi A
Colloids Surf B Biointerfaces; 2010 Mar; 76(1):170-8. PubMed ID: 19945828
[TBL] [Abstract][Full Text] [Related]
34. The use of inorganic salts to improve the dissolution characteristics of tablets containing Soluplus®-based solid dispersions.
Hughey JR; Keen JM; Miller DA; Kolter K; Langley N; McGinity JW
Eur J Pharm Sci; 2013 Mar; 48(4-5):758-66. PubMed ID: 23348153
[TBL] [Abstract][Full Text] [Related]
35. Preparation and characterization of emulsified solid dispersions containing docetaxel.
Chen Y; Shi Q; Chen Z; Zheng J; Xu H; Li J; Liu H
Arch Pharm Res; 2011 Nov; 34(11):1909-17. PubMed ID: 22139690
[TBL] [Abstract][Full Text] [Related]
36. Improved solubility and dissolution rate of piroxicam using gelucire 44/14 and labrasol.
Karataş A; Yüksel N; Baykara T
Farmaco; 2005 Sep; 60(9):777-82. PubMed ID: 16084514
[TBL] [Abstract][Full Text] [Related]
37. Influence of Low-Molecular-Weight Excipients on the Phase Behavior of PVPVA64 Amorphous Solid Dispersions.
Lehmkemper K; Kyeremateng SO; Degenhardt M; Sadowski G
Pharm Res; 2018 Jan; 35(1):25. PubMed ID: 29305717
[TBL] [Abstract][Full Text] [Related]
38. Pharmaceutical applications of solid dispersion systems: dissolution of griseofulvin-succinic acid eutectic mixture.
Chiou WL; Niazi S
J Pharm Sci; 1976 Aug; 65(8):1212-4. PubMed ID: 978439
[TBL] [Abstract][Full Text] [Related]
39. Effect of drug-polymer interactions on the aqueous solubility of milled solid dispersions.
Al-Obaidi H; Lawrence MJ; Shah S; Moghul H; Al-Saden N; Bari F
Int J Pharm; 2013 Mar; 446(1-2):100-5. PubMed ID: 23410988
[TBL] [Abstract][Full Text] [Related]
40. An investigation into the use of polymer blends to improve the printability of and regulate drug release from pharmaceutical solid dispersions prepared via fused deposition modeling (FDM) 3D printing.
Alhijjaj M; Belton P; Qi S
Eur J Pharm Biopharm; 2016 Nov; 108():111-125. PubMed ID: 27594210
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]